Endometriosis Trial, Recruiting NCT06356831 Sponsor: Centre Hospitalier Intercommunal Creteil Condition: Endometriosis
Back to Endometriosis

Endometriosis Trial, Recruiting

NCT06356831
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have endometriosis affecting the wall of your abdomen (belly), confirmed by symptoms and scans such as MRI and ultrasound.
  • Your abdominal wall endometriosis causes noticeable symptoms, such as significant pain, bothersome bleeding, or a clear impact on your day-to-day quality of life.

Who may not be able to join:

  • Your endometriosis is located in the deep pelvic muscles or other internal areas (such as the hip, pelvic floor, or surrounding muscles), rather than the front wall of the abdomen.
  • You are under 18 years old.
  • You are currently pregnant (at any stage of pregnancy).
  • You have a condition that affects your blood's ability to clot, whether inherited or developed over time.
  • You have an active widespread infection or an infection at a scar site at the time of joining the trial.
  • You have a reason why you cannot have an MRI scan (confirm with trial site).
  • You have a medical or surgical procedure planned during the study period that could interfere with the trial.
  • You are unable to understand the information given to you about the trial.
  • You are not registered with the French social security system (confirm with trial site).
  • You are under a legal protection order such as guardianship or curatorship (confirm with trial site).
  • The growth or nodule being looked at is found to be cancerous or related to a tumour.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Léo RAZAKAMAMANTSOA, CHIC

Phone: 0157023567

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Intercommunal Creteil
Registry
ClinicalTrials.gov
Start date
15 June 2024
Est. completion
31 July 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

creation of a national registry for the removal of nodules by cryoablation or surgery for parietal endometriosis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov